Dergiler / Eurasian Journal of Medical Investigation / 2020 / Cilt: 4 - Sayı: 2

The Mean Platelet Volume to Lymphocyte Ratio: A New Prognostic Marker in Resected Gastric Cancer

Sayfa
155–160
Yayın Tarihi
2022-10-12
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

A significant correlationwas found between MPVLR and gender (p=0.036), lymphocyte count (p

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Objectives: Gastric cancer is the fourth most common cancer.
📊
Temel Bulgular & Veri:In this study, we aimed to investigate the prognostic value ofMean Platelet Volume to Lymphocyte Ratio (MPVLR).Methods: Eighty patients who underwent curative resection between January 2014 and December 2018 were includedin the study.
💡
Sonuç & Katkı:A significant correlationwas found between MPVLR and gender (p=0.036), lymphocyte count (p
🔬Tür:Araştırma Makalesi
📍Kapsam:2014 Verileri
⚙️Değişkenler:Alan Parametreleri

Abstract

Objectives: Gastric cancer is the fourth most common cancer. Inflammation is a crucial component of tumor progression.Platelet-to-Lymphocyte Ratio (PLR) is a prognostic indicator in many cancer types. Mean Platelet Volume (MPV)is a parameter that reflects platelet function and activity. In this study, we aimed to investigate the prognostic value ofMean Platelet Volume to Lymphocyte Ratio (MPVLR).Methods: Eighty patients who underwent curative resection between January 2014 and December 2018 were includedin the study. Clinicopathological parameters and laboratory analyzes of the patients were obtained from computerrecords retrospectively. MPVLR cut off value was determined via receiver operating characteristic (ROC) curve analysis(low MPVLR: 4.30). MPVLR and clinicopathological characteristics were analyzed by univariate andmultivariate analysis.Results: Median survival (OS) was 24 months, and median disease-free survival (DFS) was 16 months. A significant correlationwas found between MPVLR and gender (p=0.036), lymphocyte count (p

🔖

Bu Makaleye Atıf Yap

ALTINBAŞ, M., EREN, T., ÇILBIR, E., ŞAHİNLİ, H., TÜRKER, S. (2022). The Mean Platelet Volume to Lymphocyte Ratio: A New Prognostic Marker in Resected Gastric Cancer. Eurasian Journal of Medical Investigation, Cilt: 4 - Sayı: 2, 155–160. https://ajindex.com/articles/508691

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (1)

  1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin 2011;61:69–90. [CrossRef ] 2. Sitarz R, Skierucha M, Mielko J, Offerhaus GJA, Maciejewski R, Polkowski WP. Gastric cancer: epidemiology, prevention, classification, and treatment. Cancer Manag Res 2018;10:239–48. 3. Hayes T, Smyth E, Riddell A, Allum W. Staging in Esophageal and Gastric Cancers. Hematol Oncol Clin North Am 2017;31:427– 40. [CrossRef ] 4. Cendan JC, Behrns KE. Associated neoplastic disease in inflammatory bowel disease. Surg Clin North Am 2007;87:659–72. 5. Coffelt SB, de Visser KE. Cancer: Inflammation lights the way to metastasis. Nature 2014;507:48–9. [CrossRef ] 6. Shalapour S, Karin M. Immunity, inflammation, and cancer: an eternal fight between good and evil. J Clin Invest 2015;125:3347– 55. [CrossRef ] 7. Orditura M, Galizia G, Diana A, Saccone C, Cobellis L, Ventriglia J, et al. Neutrophil to lymphocyte ratio (NLR) for prediction of distant metastasis-free survival (DMFS) in early breast cancer: a propensity score-matched analysis. ESMO Open 2016;1:e000038. [CrossRef ] 8. Pasini FS, Zilberstein B, Snitcovsky I, Roela RA, Mangone FR, Ribeiro U, Jr., et al. A gene expression profile related to immune dampening in the tumor microenvironment is associated with poor prognosis in gastric adenocarcinoma. J Gastroenterol 2014;49:1453–66. [CrossRef ] 9. Coussens LM, Jacks T. Genetic and cellular mechanisms of oncogenesis. Curr Opin Genet Dev 2008;18:1–2. [CrossRef ] 10. Zhang H, Zhang L, Zhu K, Shi B, Yin Y, Zhu J, et al. Prognostic Significance of Combination of Preoperative Platelet Count and Neutrophil-Lymphocyte Ratio (COP-NLR) in Patients with Non-Small Cell Lung Cancer: Based on a Large Cohort Study. PLoS One 2015;10:e0126496. [CrossRef ] 11. Lian L, Xia YY, Zhou C, Shen XM, Li XL, Han SG, et al. Mean platelet volume predicts chemotherapy response and prognosis in patients with unresectable gastric cancer. Oncol Lett 2015;10:3419–24. [CrossRef ] 12. Inagaki N, Kibata K, Tamaki T, Shimizu T, Nomura S. Prognostic impact of the mean platelet volume/platelet count ratio in terms of survival in advanced non-small cell lung cancer. Lung Cancer 2014;83:97–101. [CrossRef ] 13. Kurtul A, Acikgoz SK. Usefulness of Mean Platelet Volume- to-Lymphocyte Ratio for Predicting Angiographic No-Reflow and Short-Term Prognosis After Primary Percutaneous Coronary Intervention in Patients With ST-Segment Elevation Myocardial Infarction. Am J Cardiol 2017;12